{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:51:52Z","timestamp":1792266712168,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:00:00Z","timestamp":1444867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2527-4","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:34:56Z","timestamp":1444869296000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma"],"prefix":"10.1007","volume":"95","author":[{"given":"S.","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A. M.","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Edesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Zahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Maghfoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,15]]},"reference":[{"key":"2527_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361\u20131392","journal-title":"Blood"},{"key":"2527_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12253-008-9043-y","volume":"14","author":"A Illes","year":"2008","unstructured":"Illes A, Simon Z, Toth E et al (2008) Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres. Pathol Oncol Res 14:411\u2013421","journal-title":"Pathol Oncol Res"},{"key":"2527_CR3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346\u20131356","journal-title":"Am J Surg Pathol"},{"key":"2527_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","volume":"26","author":"L Nogova","year":"2008","unstructured":"Nogova L, Reineke T, Brillant C et al (2008) Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group. J Clin Oncol 26:434\u2013439","journal-title":"J Clin Oncol"},{"key":"2527_CR5","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/annonc\/mdi323","volume":"16","author":"L Nogova","year":"2005","unstructured":"Nogova L, Reineke T, Eich HT et al (2005) Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin study group (GHSG). Ann Oncol 16:1683\u20131687","journal-title":"Ann Oncol"},{"key":"2527_CR6","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood-2004-02-0567","volume":"104","author":"P Feugier","year":"2004","unstructured":"Feugier P, Labouyrie E, Djeridane M et al (2004) Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation. Blood 104:2675\u20132681","journal-title":"Blood"},{"key":"2527_CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2407-14-332","volume":"14","author":"S Hartmann","year":"2014","unstructured":"Hartmann S, Eray M, Doring C et al (2014) Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer 14:332","journal-title":"BMC Cancer"},{"key":"2527_CR8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1080\/1042819031000123528","volume":"44","author":"JZ Huang","year":"2003","unstructured":"Huang JZ, Weisenburger DD, Vose JM et al (2003) Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma. A report of 21 cases from the Nebraska lymphoma study group. Leuk Lymphoma 44:1903\u20131910","journal-title":"Leuk Lymphoma"},{"key":"2527_CR9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1200\/JCO.2013.53.2069","volume":"32","author":"RH Advani","year":"2014","unstructured":"Advani RH, Horning SJ, Hoppe RT et al (2014) Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 32:912\u2013918","journal-title":"J Clin Oncol"},{"key":"2527_CR10","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2011-06-361055","volume":"118","author":"DA Eichenauer","year":"2011","unstructured":"Eichenauer DA, Fuchs M, Pluetschow A et al (2011) Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin study group. Blood 118:4363\u20134365","journal-title":"Blood"},{"key":"2527_CR11","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/bmt.2013.88","volume":"48","author":"S Akhtar","year":"2013","unstructured":"Akhtar S, Al-Sugair AS, Abouzied M et al (2013) Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT. Bone Marrow Transplant 48:1530\u20131536","journal-title":"Bone Marrow Transplant"},{"key":"2527_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"2527_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/10428190701843213","volume":"49","author":"S Akhtar","year":"2008","unstructured":"Akhtar S, Weshi AE, Rahal M et al (2008) Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: a single institution result of 168 patients. Leuk Lymphoma 49:769\u2013778","journal-title":"Leuk Lymphoma"},{"key":"2527_CR14","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/annonc\/mdq063","volume":"21","author":"C Jackson","year":"2010","unstructured":"Jackson C, Sirohi B, Cunningham D et al (2010) Lymphocyte-predominant Hodgkin lymphoma\u2014clinical features and treatment outcomes from a 30-year experience. Ann Oncol 21:2061\u20132068","journal-title":"Ann Oncol"},{"key":"2527_CR15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2013.03.008","volume":"19","author":"M Karuturi","year":"2013","unstructured":"Karuturi M, Hosing C, Fanale M et al (2013) High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma. Biol Blood Marrow Transplant 19:991\u2013994","journal-title":"Biol Blood Marrow Transplant"},{"key":"2527_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V et al (2010) Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the adult lymphoma study group. Cancer 116:631\u2013639","journal-title":"Cancer"},{"key":"2527_CR17","doi-asserted-by":"crossref","first-page":"1a","DOI":"10.1182\/blood-2006-04-016253","volume":"108","author":"P Bierman","year":"2006","unstructured":"Bierman P, Naushad H, Loberiza F et al (2006) High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (AHSCT) for lymphocyte predominant Hodgkin\u2019s disease. Blood 108:1a\u20131062a","journal-title":"Blood"},{"key":"2527_CR18","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood-2013-12-541078","volume":"123","author":"KH Xing","year":"2014","unstructured":"Xing KH, Connors JM, Lai A et al (2014) Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood 123:3567\u20133573","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2527-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2527-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2527-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T20:02:55Z","timestamp":1599681775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2527-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,15]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2527"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2527-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,15]]}}}